Pages that link to "Q35164536"
Jump to navigation
Jump to search
The following pages link to Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections (Q35164536):
Displaying 50 items.
- Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model (Q24616179) (← links)
- Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection (Q26770175) (← links)
- Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection (Q26776155) (← links)
- Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection (Q26996462) (← links)
- Recent changes in Clostridium difficile infection (Q27022537) (← links)
- Clostridium difficile infection: Updates in management (Q30239988) (← links)
- Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis (Q33598247) (← links)
- Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study (Q33729925) (← links)
- Epidemiology of Clostridium difficile infection (Q34027474) (← links)
- Clostridium: transmission difficile? (Q34162219) (← links)
- Clostridium difficile infection in the inflammatory bowel disease patient. (Q34234668) (← links)
- Clostridium difficile colitis: a review (Q34260389) (← links)
- Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies (Q34306091) (← links)
- Synthetic polymers active against Clostridium difficile vegetative cell growth and spore outgrowth (Q34408053) (← links)
- Persistent and Recurrent Clostridium difficile Colitis (Q34670156) (← links)
- Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies (Q34801881) (← links)
- Challenges of Clostridium difficile infection (Q35017907) (← links)
- Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. (Q35044119) (← links)
- Fidaxomicin therapy in critically ill patients with Clostridium difficile infection. (Q35076869) (← links)
- Discovery of selective inhibitors of the Clostridium difficile dehydroquinate dehydratase (Q35107124) (← links)
- Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. (Q35129079) (← links)
- Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection (Q35867850) (← links)
- Breakthroughs in the treatment and prevention of Clostridium difficile infection (Q35918566) (← links)
- Antimicrobial-resistant strains of Clostridium difficile from North America (Q36018766) (← links)
- Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response (Q36019350) (← links)
- Models for the study of Clostridium difficile infection (Q36019356) (← links)
- Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. (Q36075884) (← links)
- Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain (Q36379411) (← links)
- In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent (Q36455915) (← links)
- Clostridium difficile infection: new insights into management (Q36523440) (← links)
- Emerging therapies for Clostridium difficile infection - focus on fidaxomicin (Q36984883) (← links)
- Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes (Q36996876) (← links)
- Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price (Q37092512) (← links)
- Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea (Q37124032) (← links)
- A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany (Q37297999) (← links)
- Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment (Q37334099) (← links)
- Clinical factors associated with development of severe-complicated Clostridium difficile infection (Q37356094) (← links)
- Clostridium difficile infection: management strategies for a difficult disease (Q37519138) (← links)
- Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance (Q37588248) (← links)
- Nosocomial diarrhea: a review of pathophysiology, etiology, and treatment strategies (Q37992488) (← links)
- Significant publications on infectious diseases pharmacotherapy in 2011. (Q38045269) (← links)
- Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures (Q38051245) (← links)
- Epidemiology, diagnosis and treatment of Clostridium difficile infection (Q38068605) (← links)
- Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection (Q38072208) (← links)
- Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic (Q38106746) (← links)
- Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis. (Q38107547) (← links)
- New drugs and strategies for management of Clostridium difficile colitis (Q38113471) (← links)
- Therapy of Clostridium difficile infection: perspectives on a changing paradigm (Q38139991) (← links)
- Fidaxomicin: a review of its use in patients with Clostridium difficile infection (Q38153607) (← links)
- Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation (Q38175865) (← links)